Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

National Institutes of Health

This source publishes only summary fields for this notice. Open the official notice for the full scope of work.

Deadline

7 Jan 2028(493 days left)

Published

28 Oct 2024(22 months ago)

Contract value

Not published

Location

United States

Reference

356874

First seen

5 hours ago